Exhibit 31.1
                            CERTIFICATION PURSUANT TO
                  SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

        I, Thomas H. White, certify that:

        1. I have reviewed this quarterly report on Form 10-QSB of NeoGenomics,
Inc.;

        2. Based on my knowledge, this quarterly report does not contain any untrue
statement of a material fact or omit to state a material fact necessary to make
the statements made, in light of the circumstances under which such statements
were made, not misleading with respect to the period covered by this quarterly
report;

        3. Based on my knowledge, the financial statements, and other financial
information included in this quarterly report, fairly present in all material
respects the financial condition, results of operations and cash flows of the
registrant as of, and for, the period presented in this quarterly report;

        4. I am responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the
registrant and have:

                a) designed such disclosure controls and procedures to ensure that
                   material information relating to the registrant, including its
                   consolidated subsidiaries, is made known to us by others within
                   those entities, particularly during the period in which this
                   quarterly report is being prepared;

                b) evaluated the effectiveness of the registrant's disclosure
                   controls and procedures as of a date within 90 days prior to the
                   filing date of this quarterly report (the "Evaluation Date"); and

                c) presented in this quarterly report our conclusions about the
                   effectiveness of the disclosure controls and procedures based on
                   our evaluation as of the Evaluation Date;

        5. I have disclosed, based on our most recent evaluation, to the
registrant's auditors and the audit committee of registrant's board of directors
(or persons performing the equivalent function):

                a) all significant deficiencies in the design or operation of
                   internal controls which could adversely affect the registrant's
                   ability to record, process, summarize and report financial data
                   and have identified for the registrant's auditors any material
                   weaknesses in internal controls; and

                b) any fraud, whether or not material, that involves management or
                   other employees who have a significant role in the registrant's
                   internal controls; and

        6. I have indicated in this quarterly report whether or not there were
significant changes in internal controls or in other factors that could
significantly affect internal controls subsequent to the date of our most recent
evaluation, including any corrective actions with regard to significant
deficiencies and material weaknesses.

   Date:   November 14, 2003                          /s/ Thomas H. White
                                                          Thomas H. White
                                                          Chief Executive and
                                                          Principal Financial Officer